Stock / equity
WVE Wave Life Sciences, Inc.
- Company
- Wave Life Sciences, Inc.
- Security
- Equity
- Size, estimated from filings
- Small cap ($300M – $2B)
- Insiders on record
- 13
- Latest trade on record
- October 5, 2026
WVE (Wave Life Sciences, Inc.) has 130 disclosed insider transactions from 13 insiders in the last 12 months (6 open-market buys, 47 sales, about $104.0M at reported prices) and 0 congressional trades from 0 members of Congress. The most recent disclosure was filed October 7, 2026.
Share price
Price and chart by TradingView for Wave Life Sciences, Inc.. US share prices here are delayed, not real-time. The trade records on this page come from government filings, not from this chart.
WVE in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
8 people account for the disclosed buying and selling in WVE over the last 12 months; the most active is RA CAPITAL MANAGEMENT, L.P. with $55M.
Prices insiders traded at
What price did insiders buy and sell at? Each marker is one open-market trade at the share price reported on its Form 4.
Insiders reported 53 open-market trades in WVE since Nov 13, 2025, at prices from $5.29 to $20.25; the most recent was a sale at $5.29 on Aug 12, 2026. These are the prices on the filings, not adjusted for stock splits, and not a market price series.
Insider holdings over time
Is an insider building or unwinding a position? Shares held directly after each filing.
Rawcliffe Adrian reported 10,700 shares held after the latest filing, against 12,700 at the first on record.
Insiders trading WVE
Everyone who filed a Form 4 for this ticker, by number of rows on record. "Bought" and "sold" count open-market purchases (code P) and sales only; awards, option exercises and shares withheld for tax are in the row count but not in those two columns.
| Insider | Role | Rows | Bought | Sold | Value bought | Value sold | Latest |
|---|---|---|---|---|---|---|---|
| Francis Chris | See Remarks | 36 | 0 | 14 | — | $7.1M | February 26, 2026 |
| Tan Aik Na | Director | 19 | 0 | 9 | — | $1.8M | October 5, 2026 |
| Moran Kyle | Chief Financial Officer | 19 | 0 | 7 | — | $4.2M | February 9, 2026 |
| HENRY CHRISTIAN O | Director | 12 | 0 | 4 | — | $1.4M | October 5, 2026 |
| Wagner Heidi L | Director | 10 | 0 | 3 | — | $231K | October 5, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 7 | 5 | 0 | $54.6M | — | October 5, 2026 |
| Rawcliffe Adrian | Director | 7 | 0 | 3 | — | $807K | October 5, 2026 |
| TAKANASHI KEN | Director | 5 | 0 | 1 | — | $23K | October 5, 2026 |
| CORRIGAN MARK | Director | 4 | 0 | 2 | — | $217K | October 5, 2026 |
| Verdine Gregory L. | Director | 4 | 0 | 2 | — | $269K | October 5, 2026 |
| BOLNO PAUL | President and CEO | 3 | 0 | 1 | — | $141K | February 9, 2026 |
| Vargeese Chandra | See Remarks | 3 | 0 | 1 | — | $43K | February 9, 2026 |
| GLAXOSMITHKLINE PLC | Insider | 3 | 3 | 0 | $66.8M | — | December 11, 2025 |
What kind of transactions these are 5 Form 4 codes
| Code | Meaning | Rows | Shares | Value at reported prices |
|---|---|---|---|---|
| S | Open-market sale | 47 | 1,122,704 | $16.2M |
| M | Option exercise or conversion | 46 | 1,801,660 | $5.2M |
| A | Grant or award | 29 | 2,968,600 | — |
| P | Open-market purchase | 8 | 16,335,426 | $121.4M |
| C | Conversion of a derivative | 2 | 7,802,696 | — |
What each code means: Form 4 transaction codes.
Insider transactions
| Filer | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| HENRY CHRISTIAN O | Other A | October 5, 2026 | October 7, 2026 | 2d | 64,000 | — | — | derivative | Form 4 ↗ | |
| HENRY CHRISTIAN O | Other A | October 5, 2026 | October 7, 2026 | 2d | 10,700 | — | — | Form 4 ↗ | ||
| Wagner Heidi L | Other A | October 5, 2026 | October 7, 2026 | 2d | 64,000 | — | — | derivative | Form 4 ↗ | |
| Wagner Heidi L | Other A | October 5, 2026 | October 7, 2026 | 2d | 10,700 | — | — | Form 4 ↗ | ||
| Rawcliffe Adrian | Other A | October 5, 2026 | October 7, 2026 | 2d | 64,000 | — | — | derivative | Form 4 ↗ | |
| Rawcliffe Adrian | Other A | October 5, 2026 | October 7, 2026 | 2d | 10,700 | — | — | Form 4 ↗ | ||
| CORRIGAN MARK | Other A | October 5, 2026 | October 7, 2026 | 2d | 64,000 | — | — | derivative | Form 4 ↗ | |
| CORRIGAN MARK | Other A | October 5, 2026 | October 7, 2026 | 2d | 10,700 | — | — | Form 4 ↗ | ||
| TAKANASHI KEN | Other A | October 5, 2026 | October 7, 2026 | 2d | 64,000 | — | — | derivative | Form 4 ↗ | |
| TAKANASHI KEN | Other A | October 5, 2026 | October 7, 2026 | 2d | 10,700 | — | — | Form 4 ↗ | ||
| Tan Aik Na | Other A | October 5, 2026 | October 7, 2026 | 2d | 64,000 | — | — | derivative | Form 4 ↗ | |
| Tan Aik Na | Other A | October 5, 2026 | October 7, 2026 | 2d | 10,700 | — | — | Form 4 ↗ | ||
| Verdine Gregory L. | Other A | October 5, 2026 | October 7, 2026 | 2d | 64,000 | — | — | derivative | Form 4 ↗ | |
| Verdine Gregory L. | Other A | October 5, 2026 | October 7, 2026 | 2d | 10,700 | — | — | Form 4 ↗ | ||
| RA CAPITAL MANAGEMENT, L.P. | Other A | October 5, 2026 | October 7, 2026 | 2d | 64,000 | — | — | indirectderivative | Form 4 ↗ | |
| RA CAPITAL MANAGEMENT, L.P. | Other A | October 5, 2026 | October 7, 2026 | 2d | 10,700 | — | — | indirect | Form 4 ↗ | |
| Wagner Heidi L | Option / conversion M | August 11, 2026 | August 13, 2026 | 2d | 7,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Wagner Heidi L | Sell S | August 11, 2026 | August 13, 2026 | 2d | 7,000 | $6 | $42K | 10b5-1 plan | Form 4 ↗ | |
| Wagner Heidi L | Option / conversion M | August 11, 2026 | August 13, 2026 | 2d | 7,000 | $6 | $42K | 10b5-1 plan | Form 4 ↗ | |
| Rawcliffe Adrian | Sell S | August 12, 2026 | August 13, 2026 | 1d | 12,700 | $5 | $67K | 10b5-1 plan | Form 4 ↗ | |
| TAKANASHI KEN | Sell S | August 11, 2026 | August 13, 2026 | 2d | 3,864 | $6 | $23K | 10b5-1 plan | Form 4 ↗ | |
| Tan Aik Na | Sell S | August 11, 2026 | August 13, 2026 | 2d | 432 | $6 | $2,596 | 10b5-1 plan | Form 4 ↗ | |
| RA CAPITAL MANAGEMENT, L.P. | Buy P | March 30, 2026 | March 30, 2026 | 0d | 971,091 | $7 | $6.3M | indirect | Form 4 ↗ | |
| RA CAPITAL MANAGEMENT, L.P. | Buy P | March 27, 2026 | March 30, 2026 | 3d | 2,495,623 | $6 | $16.0M | indirect | Form 4 ↗ | |
| RA CAPITAL MANAGEMENT, L.P. | Buy P | March 26, 2026 | March 30, 2026 | 4d | 351,224 | $6 | $2.2M | indirect | Form 4 ↗ | |
| RA CAPITAL MANAGEMENT, L.P. | Buy P | March 26, 2026 | March 30, 2026 | 4d | 4,954,558 | $6 | $30.0M | indirect | Form 4 ↗ | |
| TAKANASHI KEN | Exchange C | March 23, 2026 | March 26, 2026 | 3d | 3,901,348 | — | — | indirectderivative | Form 4 ↗ | |
| TAKANASHI KEN | Exchange C | March 23, 2026 | March 26, 2026 | 3d | 3,901,348 | — | — | indirect | Form 4 ↗ | |
| Francis Chris | Option / conversion M | February 26, 2026 | February 27, 2026 | 1d | 15,294 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Francis Chris | Option / conversion M | February 26, 2026 | February 27, 2026 | 1d | 17,900 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Francis Chris | Sell S | February 26, 2026 | February 27, 2026 | 1d | 15,294 | $15 | $229K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Option / conversion M | February 26, 2026 | February 27, 2026 | 1d | 15,294 | $5 | $73K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Sell S | February 26, 2026 | February 27, 2026 | 1d | 17,900 | $15 | $270K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Option / conversion M | February 26, 2026 | February 27, 2026 | 1d | 17,900 | $4 | $69K | 10b5-1 plan | Form 4 ↗ | |
| Moran Kyle | Other A | February 5, 2026 | February 11, 2026 | 6d | 273,750 | — | — | latederivative | Form 4 ↗ | |
| Moran Kyle | Sell S | February 9, 2026 | February 11, 2026 | 2d | 3,588 | $13 | $48K | Form 4 ↗ | ||
| Moran Kyle | Other A | February 5, 2026 | February 11, 2026 | 6d | 45,625 | — | — | late | Form 4 ↗ | |
| BOLNO PAUL | Other A | February 5, 2026 | February 11, 2026 | 6d | 1,000,000 | — | — | latederivative | Form 4 ↗ | |
| BOLNO PAUL | Sell S | February 9, 2026 | February 11, 2026 | 2d | 10,480 | $13 | $141K | Form 4 ↗ | ||
| BOLNO PAUL | Other A | February 5, 2026 | February 11, 2026 | 6d | 165,000 | — | — | late | Form 4 ↗ | |
| Francis Chris | Other A | February 5, 2026 | February 11, 2026 | 6d | 232,500 | — | — | latederivative | Form 4 ↗ | |
| Francis Chris | Sell S | February 9, 2026 | February 11, 2026 | 2d | 1,883 | $13 | $25K | Form 4 ↗ | ||
| Francis Chris | Other A | February 5, 2026 | February 11, 2026 | 6d | 38,750 | — | — | late | Form 4 ↗ | |
| Vargeese Chandra | Other A | February 5, 2026 | February 11, 2026 | 6d | 273,750 | — | — | latederivative | Form 4 ↗ | |
| Vargeese Chandra | Sell S | February 9, 2026 | February 11, 2026 | 2d | 3,228 | $13 | $43K | Form 4 ↗ | ||
| Vargeese Chandra | Other A | February 5, 2026 | February 11, 2026 | 6d | 45,625 | — | — | late | Form 4 ↗ | |
| Francis Chris | Option / conversion M | January 2, 2026 | January 6, 2026 | 4d | 9,375 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Francis Chris | Sell S | January 2, 2026 | January 6, 2026 | 4d | 1,295 | $17 | $22K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Sell S | January 2, 2026 | January 6, 2026 | 4d | 8,080 | $16 | $129K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Option / conversion M | January 2, 2026 | January 6, 2026 | 4d | 9,375 | $3 | $29K | 10b5-1 plan | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Buy P | December 11, 2025 | December 15, 2025 | 4d | 1,470,000 | $19 | $27.9M | indirect | Form 4 ↗ | |
| Rawcliffe Adrian | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 42,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Rawcliffe Adrian | Sell S | December 8, 2025 | December 10, 2025 | 2d | 42,000 | $15 | $630K | 10b5-1 plan | Form 4 ↗ | |
| Rawcliffe Adrian | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 42,000 | $6 | $251K | 10b5-1 plan | Form 4 ↗ | |
| Wagner Heidi L | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 14,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Wagner Heidi L | Sell S | December 8, 2025 | December 10, 2025 | 2d | 7,000 | $14 | $98K | 10b5-1 plan | Form 4 ↗ | |
| Wagner Heidi L | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 7,000 | $6 | $42K | 10b5-1 plan | Form 4 ↗ | |
| Wagner Heidi L | Sell S | December 8, 2025 | December 10, 2025 | 2d | 7,000 | $13 | $91K | 10b5-1 plan | Form 4 ↗ | |
| Wagner Heidi L | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 7,000 | $6 | $42K | 10b5-1 plan | Form 4 ↗ | |
| HENRY CHRISTIAN O | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 30,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| HENRY CHRISTIAN O | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 15,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| HENRY CHRISTIAN O | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 42,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| HENRY CHRISTIAN O | Sell S | December 8, 2025 | December 10, 2025 | 2d | 30,000 | $18 | $541K | 10b5-1 plan | Form 4 ↗ | |
| HENRY CHRISTIAN O | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 30,000 | $5 | $138K | 10b5-1 plan | Form 4 ↗ | |
| HENRY CHRISTIAN O | Sell S | December 8, 2025 | December 10, 2025 | 2d | 15,000 | $14 | $211K | 10b5-1 plan | Form 4 ↗ | |
| HENRY CHRISTIAN O | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 15,000 | $4 | $53K | 10b5-1 plan | Form 4 ↗ | |
| HENRY CHRISTIAN O | Sell S | December 8, 2025 | December 10, 2025 | 2d | 42,000 | $13 | $536K | 10b5-1 plan | Form 4 ↗ | |
| HENRY CHRISTIAN O | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 42,000 | $6 | $251K | 10b5-1 plan | Form 4 ↗ | |
| HENRY CHRISTIAN O | Sell S | December 8, 2025 | December 10, 2025 | 2d | 6,445 | $13 | $82K | 10b5-1 plan | Form 4 ↗ | |
| Tan Aik Na | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 21,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Tan Aik Na | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 21,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Tan Aik Na | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 45,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Tan Aik Na | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 32,230 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Tan Aik Na | Sell S | December 8, 2025 | December 10, 2025 | 2d | 21,000 | $13 | $268K | 10b5-1 plan | Form 4 ↗ | |
| Tan Aik Na | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 21,000 | $6 | $125K | 10b5-1 plan | Form 4 ↗ | |
| Tan Aik Na | Sell S | December 8, 2025 | December 10, 2025 | 2d | 21,000 | $13 | $268K | 10b5-1 plan | Form 4 ↗ | |
| Tan Aik Na | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 21,000 | $4 | $74K | 10b5-1 plan | Form 4 ↗ | |
| Tan Aik Na | Sell S | December 8, 2025 | December 10, 2025 | 2d | 25,000 | $15 | $375K | 10b5-1 plan | Form 4 ↗ | |
| Tan Aik Na | Sell S | December 8, 2025 | December 10, 2025 | 2d | 20,000 | $13 | $255K | 10b5-1 plan | Form 4 ↗ | |
| Tan Aik Na | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 45,000 | $5 | $206K | 10b5-1 plan | Form 4 ↗ | |
| Tan Aik Na | Sell S | December 8, 2025 | December 10, 2025 | 2d | 17,230 | $15 | $258K | 10b5-1 plan | Form 4 ↗ | |
| Tan Aik Na | Sell S | December 8, 2025 | December 10, 2025 | 2d | 15,000 | $13 | $191K | 10b5-1 plan | Form 4 ↗ | |
| Tan Aik Na | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 32,230 | $5 | $173K | 10b5-1 plan | Form 4 ↗ | |
| Tan Aik Na | Sell S | December 8, 2025 | December 10, 2025 | 2d | 7,494 | $15 | $112K | 10b5-1 plan | Form 4 ↗ | |
| Tan Aik Na | Sell S | December 8, 2025 | December 10, 2025 | 2d | 7,494 | $13 | $96K | 10b5-1 plan | Form 4 ↗ | |
| Verdine Gregory L. | Sell S | December 8, 2025 | December 10, 2025 | 2d | 7,980 | $14 | $112K | 10b5-1 plan | Form 4 ↗ | |
| Verdine Gregory L. | Sell S | December 8, 2025 | December 10, 2025 | 2d | 12,020 | $13 | $157K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 22,500 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 50,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 168,231 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 125,300 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 75,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Francis Chris | Sell S | December 8, 2025 | December 10, 2025 | 2d | 22,500 | $14 | $317K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 22,500 | $3 | $64K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Sell S | December 8, 2025 | December 10, 2025 | 2d | 50,000 | $16 | $800K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 50,000 | $10 | $524K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Sell S | December 8, 2025 | December 10, 2025 | 2d | 122,349 | $14 | $1.7M | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 122,349 | $5 | $581K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Sell S | December 8, 2025 | December 10, 2025 | 2d | 17,900 | $15 | $269K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 17,900 | $4 | $69K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Sell S | December 8, 2025 | December 10, 2025 | 2d | 37,500 | $14 | $528K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 37,500 | $3 | $118K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Sell S | December 8, 2025 | December 10, 2025 | 2d | 9,375 | $15 | $141K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 9,375 | $3 | $29K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Sell S | December 8, 2025 | December 10, 2025 | 2d | 45,882 | $15 | $665K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 45,882 | $5 | $218K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Sell S | December 8, 2025 | December 10, 2025 | 2d | 107,400 | $15 | $1.6M | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 107,400 | $4 | $416K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Sell S | December 8, 2025 | December 10, 2025 | 2d | 28,125 | $15 | $408K | 10b5-1 plan | Form 4 ↗ | |
| Francis Chris | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 28,125 | $3 | $88K | 10b5-1 plan | Form 4 ↗ | |
| Moran Kyle | Other A | December 9, 2025 | December 10, 2025 | 1d | 50,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Moran Kyle | Other A | December 9, 2025 | December 10, 2025 | 1d | 36,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Moran Kyle | Other A | December 8, 2025 | December 10, 2025 | 2d | 50,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Moran Kyle | Other A | December 8, 2025 | December 10, 2025 | 2d | 100,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Moran Kyle | Other A | December 8, 2025 | December 10, 2025 | 2d | 60,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Moran Kyle | Sell S | December 9, 2025 | December 10, 2025 | 1d | 50,000 | $20 | $1.0M | 10b5-1 plan | Form 4 ↗ | |
| Moran Kyle | Option / conversion M | December 9, 2025 | December 10, 2025 | 1d | 50,000 | $10 | $524K | 10b5-1 plan | Form 4 ↗ | |
| Moran Kyle | Sell S | December 9, 2025 | December 10, 2025 | 1d | 36 | $20 | $729 | 10b5-1 plan | Form 4 ↗ | |
| Moran Kyle | Option / conversion M | December 9, 2025 | December 10, 2025 | 1d | 36,000 | $8 | $294K | 10b5-1 plan | Form 4 ↗ | |
| Moran Kyle | Sell S | December 8, 2025 | December 10, 2025 | 2d | 50,000 | $18 | $900K | 10b5-1 plan | Form 4 ↗ | |
| Moran Kyle | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 50,000 | $5 | $238K | 10b5-1 plan | Form 4 ↗ | |
| Moran Kyle | Sell S | December 8, 2025 | December 10, 2025 | 2d | 50,000 | $13 | $660K | 10b5-1 plan | Form 4 ↗ | |
| Moran Kyle | Sell S | December 8, 2025 | December 10, 2025 | 2d | 50,000 | $15 | $750K | 10b5-1 plan | Form 4 ↗ | |
| Moran Kyle | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 100,000 | $3 | $314K | 10b5-1 plan | Form 4 ↗ | |
| Moran Kyle | Sell S | December 8, 2025 | December 10, 2025 | 2d | 60,000 | $13 | $792K | 10b5-1 plan | Form 4 ↗ | |
| Moran Kyle | Option / conversion M | December 8, 2025 | December 10, 2025 | 2d | 60,000 | $3 | $170K | 10b5-1 plan | Form 4 ↗ | |
| CORRIGAN MARK | Sell S | December 8, 2025 | December 10, 2025 | 2d | 6,515 | $14 | $92K | 10b5-1 plan | Form 4 ↗ | |
| CORRIGAN MARK | Sell S | December 8, 2025 | December 10, 2025 | 2d | 9,600 | $13 | $126K | 10b5-1 plan | Form 4 ↗ | |
| Rawcliffe Adrian | Sell S | November 13, 2025 | November 14, 2025 | 1d | 16,115 | $7 | $109K | 10b5-1 plan | Form 4 ↗ | |
| RA CAPITAL MANAGEMENT, L.P. | Buy P | November 13, 2025 | November 14, 2025 | 1d | 1,000 | $7 | $6,688 | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Buy P | September 27, 2024 | October 1, 2024 | 4d | 2,791,930 | $8 | $22.3M | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | Buy P | December 7, 2023 | January 30, 2024 | 54d | 3,300,000 | $5 | $16.5M | lateindirect | Form 4 ↗ |
Congressional trades
No member of Congress has disclosed a trade in this ticker in the filings we have parsed.
Related stocks
Tickers traded by the same people who traded WVE, by number of filers in common. It shows overlap in public filings and nothing else.
- BCYC BICYCLE THERAPEUTICS PLC 1 filer in common
- CVRX CVRx, Inc. 1 filer in common
- INVA Innoviva, Inc. 1 filer in common
- LYEL Lyell Immunopharma, Inc. 1 filer in common
- DBTX Decibel Therapeutics, Inc. 1 filer in common
- GNCA GENOCEA BIOSCIENCES, INC. 1 filer in common
- TBPH Theravance Biopharma, Inc. 1 filer in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 33 | 132 | January 30, 2024 | October 7, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insider rows are Form 4 filings for this issuer from SEC EDGAR; congressional rows are periodic transaction reports parsed from the House Clerk and the Senate eFD. Values use the reported price for Form 4 and the disclosed range for Congress. See methodology and corrections.
Not investment advice. Disclosures are shown as filed and may lag the trade or be amended. No recommendation is made or implied.